|Mr. Jay P. Shepard||Pres, CEO & Director||866.41k||N/A||1958|
|Ms. Tracy M. Woody||Chief Commercial Officer||N/A||N/A||1970|
|Dr. Jeffrey L. Cleland||Co-Founder||N/A||N/A||1965|
|Dr. Joshua Silverman Ph.D.||Co-Founder||N/A||N/A||N/A|
|Mr. Kevin Haas||VP of Fin.||N/A||N/A||1965|
Versartis, Inc. operates as an endocrine-focused biopharmaceutical company in the United States. It is developing somavaratan, a long-acting recombinant human growth hormone for the treatment of growth hormone deficiency. The company was founded in 2008 and is headquartered in Menlo Park, California.
Versartis, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.